Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 4, Issue 12, Pages 961-967Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd1904
Keywords
-
Ask authors/readers for more resources
The pharmaceutical industry is currently beleaguered by close scrutiny from the financial community, regulators and the general public. Productivity, in terms of new drug approvals, has generally been falling for almost a decade and the safety of a number of highly successful drugs has recently been brought into question. Here, we discuss whether taking an in vivo systems approach to drug discovery and development could be the paradigm shift that rescues the industry.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available